ReWalk Robotics Hopes to Raise $50M in IPO
From Boston Herald:
A company with U.S. headquarters in Marlborough that was recently awarded FDA approval to sell its robotic exoskeletons for paraplegics plans to raise $50 million in an IPO this week, possibly on Friday.
Israeli-based ReWalk Robotics is planning to sell 3.5 million shares for between $14 and $16 each, which puts it at the low end of the 13 local health care companies which have gone public since the beginning of the year, more than any other year in history. Most of those have been biotech companies, however, making ReWalk the first robotics-focused company to do so in at least a couple of years... (cont'd)
Comments (0)
This post does not have any comments. Be the first to leave a comment below.
Featured Product
Stäubli robotic tool changer solutions
Stäubli is a pioneer in the construction and development of robotic tool changing systems. Our customers benefit from our many years of expertise in all industry sectors, as well as our modular product concept, which offers three efficient solution paths: MPS COMPLETE offers preconfigured robotic tool changers for immediate use. MPS MODULAR allows the user to determine the configuration, while MPS CUSTOMIZED allows the construction of special, application-specific systems.
